Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guislaine Carcelain

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Biologicals : Journal of the International Association of Biological Standardization|March 7, 2021
Comparison of three immunoassays for infliximab trough level monitoring in paediatric inflammatory bowel diseasesJuliette Villemonteix, Valérie Guérin-El Khourouj, Jean-Pierre Hugot, et al.
Infection Control and Hospital Epidemiology|February 17, 2015
Interferon-γ release assay vs. tuberculin skin test for tuberculosis screening in exposed healthcare workers: a longitudinal multicenter comparative studyJean-Christophe Lucet, Dominique Abiteboul, Candice Estellat, et al.
Journal of Virology|August 8, 2008
Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantationKarim Sacre, Stéphanie Nguyen, Claire Deback, et al.
AIDS (London, England)|December 6, 2005
Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infectionNadia Alatrakchi, Florence Damond, Sophie Matheron, et al.
Antiviral Therapy|May 29, 2009
CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3Marguerite Guiguet, Eric Kendjo, Guislaine Carcelain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recoveryJade Ghosn, Luc Paris, Daniel Ajzenberg, et al.
Immunity, Inflammation and Disease|September 28, 2022
Comparison between enzyme-linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS-CoV-2 after symptomatic COVID-19Juliette Villemonteix, Laure Cohen, Amélie Guihot, et al.
The American Journal of the Medical Sciences|October 23, 2008
T cells subtypes in a patient with interferon-alpha induced sarcoidosisJean-Jacques Monsuez, Guislaine Carcelain, Jean-Christophe Charniot, et al.
Annals of the American Thoracic Society|July 28, 2015
Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence CountryAnne Bourgarit, Gabriel Baron, Guillaume Breton, et al.
AIDS (London, England)|March 3, 2006
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patientsAnne Bourgarit, Guislaine Carcelain, Valerie Martinez, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Biologicals : Journal of the International Association of Biological Standardization|March 7, 2021
Comparison of three immunoassays for infliximab trough level monitoring in paediatric inflammatory bowel diseasesJuliette Villemonteix, Valérie Guérin-El Khourouj, Jean-Pierre Hugot, et al.
Infection Control and Hospital Epidemiology|February 17, 2015
Interferon-γ release assay vs. tuberculin skin test for tuberculosis screening in exposed healthcare workers: a longitudinal multicenter comparative studyJean-Christophe Lucet, Dominique Abiteboul, Candice Estellat, et al.
Journal of Virology|August 8, 2008
Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantationKarim Sacre, Stéphanie Nguyen, Claire Deback, et al.
AIDS (London, England)|December 6, 2005
Proliferative, IFNgamma and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infectionNadia Alatrakchi, Florence Damond, Sophie Matheron, et al.
Antiviral Therapy|May 29, 2009
CD4+ T-cell percentage is an independent predictor of clinical progression in AIDS-free antiretroviral-naive patients with CD4+ T-cell counts >200 cells/mm3Marguerite Guiguet, Eric Kendjo, Guislaine Carcelain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recoveryJade Ghosn, Luc Paris, Daniel Ajzenberg, et al.
Immunity, Inflammation and Disease|September 28, 2022
Comparison between enzyme-linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS-CoV-2 after symptomatic COVID-19Juliette Villemonteix, Laure Cohen, Amélie Guihot, et al.
The American Journal of the Medical Sciences|October 23, 2008
T cells subtypes in a patient with interferon-alpha induced sarcoidosisJean-Jacques Monsuez, Guislaine Carcelain, Jean-Christophe Charniot, et al.
Annals of the American Thoracic Society|July 28, 2015
Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence CountryAnne Bourgarit, Gabriel Baron, Guillaume Breton, et al.
AIDS (London, England)|March 3, 2006
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patientsAnne Bourgarit, Guislaine Carcelain, Valerie Martinez, et al.
Pageof 8